1. Search Result
Search Result
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-N7934


    HCV Infection Inflammation/Immunology Neurological Disease
    Trachelogenin ((-)-Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Trachelogenin inhibits HCVcc infection and HCVpp cell entry in a dose-dependent manner with an IC50 of 0.325 and 0.259 μg/mL in HCVcc and HCVpp models, respectively. Trachelogenin exhibits effective antiviral, anti-inflammatory and analgesic effects.